Compagnie Lombard Odier SCmA’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8
Closed -$2.78K 482
2024
Q4
$2.78K Hold
8
﹤0.01% 426
2024
Q3
$2.28K Hold
8
﹤0.01% 438
2024
Q2
$2.84K Hold
8
﹤0.01% 420
2024
Q1
$3.14K Hold
8
﹤0.01% 447
2023
Q4
$2.8K Hold
8
﹤0.01% 522
2023
Q3
$3.56K Hold
8
﹤0.01% 549
2023
Q2
$5.84K Hold
8
﹤0.01% 526
2023
Q1
$6.02K Hold
8
﹤0.01% 568
2022
Q4
$15K Hold
8
﹤0.01% 582
2022
Q3
$4K Hold
8
﹤0.01% 598
2022
Q2
$6K Hold
8
﹤0.01% 562
2022
Q1
$28K Hold
8
﹤0.01% 498
2021
Q4
$24K Hold
8
﹤0.01% 567
2021
Q3
$52K Hold
8
﹤0.01% 497
2021
Q2
$106K Hold
8
﹤0.01% 404
2021
Q1
$135K Hold
8
﹤0.01% 420
2020
Q4
$136K Buy
+8
New +$151K ﹤0.01% 363

Other funds holding KALA

Compagnie Lombard Odier SCmA's KALA Position: Q1 2025 in Review

Compagnie Lombard Odier SCmA sold out of KALA BIO (KALA) in Q1 2025, closing a stake of 8 shares — an estimated $2.78K sold.

Compagnie Lombard Odier SCmA first reported a position in KALA in Q4 2020 and held it in 17 quarters. The position peaked at $136K in Q4 2020. 25 funds tracked by Wall St. Rank hold KALA as of Q1 2025.

  • Compagnie Lombard Odier SCmA reported no remaining KALA BIO position as of Q1 2025 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 8 KALA BIO shares in Q1 2025, an estimated $2.78K.
  • Compagnie Lombard Odier SCmA first reported a position in KALA BIO in Q4 2020 and held it in 17 quarters.
  • Compagnie Lombard Odier SCmA's KALA BIO position peaked at $136K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held KALA BIO as of Q1 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2025, filed 16 Apr 2025.